News & Updates
Filter by Specialty:

Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension
In women with postpartum hypertension, treatment with combined hydrochlorothiazide (HCTZ)/lisinopril yields greater blood pressure (BP)-lowering benefit than nifedipine monotherapy, according to the results of a pilot study.
Hydrochlorothiazide–lisinopril combo bests nifedipine for BP control in postpartum hypertension
17 Feb 2023
Hypothalamic defects seen in overweight kids with PSIS
Notable phenotypic differences are present in patients with pituitary stalk interruption syndrome (PSIS) who are overweight or obese, which indicate hypothalamic defects, reports a study.
Hypothalamic defects seen in overweight kids with PSIS
16 Feb 2023
FTD/TPI-bevacizumab combo a new SoC for metastatic CRC?
A combination of trifluridine/tipiracil (FTD/TPI) and bevacizumab provided significant survival benefit when used as third-line treatment for refractory metastatic colorectal cancer (CRC) than FTD/TPI alone, findings from the phase III SUNLIGHT study suggest.
FTD/TPI-bevacizumab combo a new SoC for metastatic CRC?
16 Feb 2023
Dynapenia ups risks of falls, fractures in women with obesity
Reduced muscle strength (dynapenia) is associated with a higher risk of leg and ankle fractures in women with obesity, as shown in a study. Dynapenia also negates the protective effects of obesity on fractures of the wrist, arm, hip, spine, and other bones, thus increasing the risk of falls.
Dynapenia ups risks of falls, fractures in women with obesity
16 Feb 2023
Prophylactic aflibercept reduces vision-threatening complications without gains in visual acuity
Treatment with intravitreal aflibercept in patients with nonproliferative diabetic retinopathy but without centre-involved diabetic macular edema appears to slow disease progression and reduce the risk of developing vision-threatening complications but fall short of improving visual acuity, according to a study.